Structural Determinants for Antitoxin Identity and Insulation of Cross Talk between Homologous Toxin-Antitoxin Systems.
Toxin-antitoxin (TA) systems are ubiquitous in bacteria and archaea, where they play a pivotal role in the establishment and maintenance of dormancy. Under normal growth conditions, the antitoxin neutralizes the toxin. However, under conditions of stress, such as nutrient starvation or antibiotic treatment, cellular proteases degrade the antitoxin, and the toxin functions to arrest bacterial growth. We characterized the specificity determinants of the interactions between VapB antitoxins and VapC toxins from nontypeable Haemophilus influenzae (NTHi) in an effort to gain a better understanding of how antitoxins control toxin activity and bacterial persistence. We studied truncated and full-length antitoxins with single amino acid mutations in the toxin-binding domain. Coexpressing the toxin and antitoxin in Escherichia coli and measuring bacterial growth by dilution plating assayed the ability of the mutant antitoxins to neutralize the toxin. Our results identified two single amino acid residues (W48 and F52) in the C-terminal region of the VapB2 antitoxin necessary for its ability to neutralize its cognate VapC2 toxin. Additionally, we attempted to alter the specificity of VapB1 by making a mutation that would allow it to neutralize its noncognate toxin. A mutation in VapB1 to contain the tryptophan residue identified herein as important in the VapB2-VapC2 interaction resulted in a VapB1 mutant (the T47W mutant) that binds to and neutralizes both its cognate VapC1 and noncognate VapC2 toxins. This represents the first example of a single mutation causing relaxed specificity in a type II antitoxin.



Toxin-antitoxin systems are of particular concern in pathogenic organisms, such as nontypeable Haemophilus influenzae, as they can elicit dormancy and persistence, leading to chronic infections and failure of antibiotic treatment. Despite the importance of the TA interaction, the specificity determinants for VapB-VapC complex formation remain uncharacterized. Thus, our understanding of how antitoxins control toxin-induced dormancy and bacterial persistence requires thorough investigation of antitoxin specificity for its cognate toxin. This study characterizes the crucial residues of the VapB2 antitoxin from NTHi necessary for its interaction with VapC2 and provides the first example of a single amino acid change altering the toxin specificity of an antitoxin.
Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Lauren R
LR
Walling
Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA scott_butler@urmc.rochester.edu.|Departments of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA.|Center for RNA Biology, University of Rochester Medical Center, Rochester, New York, USA.
J Scott
JS
Butler
D000595:Amino Acid Sequence; D000992:Antitoxins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D006193:Haemophilus influenzae / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D008969:Molecular Sequence Data; D009154:Mutation; D016415:Sequence Alignment
D000992:Antitoxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins
J Biol Chem. 2009 Jan 2;284(1):276-83
18952600
Science. 2003 Sep 12;301(5639):1496-9
12970556
Nucleic Acids Res. 2016 Feb 18;44(3):1256-70
26740583
Sci Rep. 2014 May 06;4:4807
24797297
J Bacteriol. 2005 May;187(9):3151-7
15838042
Acta Biochim Pol. 2011;58(1):1-9
21394325
Cell. 2013 Aug 29;154(5):1140-50
23993101
J Biol Chem. 2014 Dec 5;289(49):34013-23
25326388
Annu Rev Microbiol. 2012;66:103-23
22994490
Protein Sci. 2012 Nov;21(11):1754-67
23011806
Handb Exp Pharmacol. 2012;(211):121-33
23090599
Protein Eng Des Sel. 2011 Jan;24(1-2):33-40
21036780
PLoS One. 2011;6(6):e21738
21738782
Mol Cell. 2003 Oct;12(4):913-23
14580342
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7403-7
21502523
Nat Commun. 2013;4:2796
24225902
Cell. 2015 Oct 22;163(3):594-606
26478181
Biotechniques. 1997 Oct;23(4):570-1, 574
9343663
Cell. 2010 Jul 9;142(1):101-11
20603017
FEMS Microbiol Rev. 2015 Jul;39(4):522-40
25796610
Nucleic Acids Res. 2012 May;40(10):4347-57
22287572
Nat Rev Microbiol. 2005 May;3(5):371-82
15864262
J Struct Biol. 2014 Dec;188(3):249-58
25450593
RNA. 2012 Jun;18(6):1267-78
22539524
J Bacteriol. 2004 May;186(9):2692-8
15090510
J Biol Chem. 2005 Feb 4;280(5):3143-50
15537630
Cell. 2011 Sep 30;147(1):147-57
21944167
J Mol Biol. 2011 Dec 16;414(5):713-22
22037005
J Biol Chem. 2014 Mar 14;289(11):7788-98
24448800
Mol Cell. 2013 Oct 24;52(2):248-54
24095282
J Bacteriol. 2015 Apr;197(7):1197-207
25622615
BMC Microbiol. 2012 Nov 19;12:263
23157645
Proc Natl Acad Sci U S A. 1983 Aug;80(15):4784-8
6308648
J Bacteriol. 2005 Jan;187(2):765-70
15629948
Cell. 2003 Jan 10;112(1):131-40
12526800
J Mol Biol. 1986 Aug 5;190(3):269-79
3023637
J Mol Biol. 1992 May 5;225(1):39-52
1316444
Mob Genet Elements. 2013 Sep 1;3(5):e26219
24251069
Nucleic Acids Res. 2012 Apr;40(7):3245-58
22140099
J Biol Chem. 2003 Aug 22;278(34):32300-6
12810711
Nat Commun. 2015 Jul 09;6:7480
26158745
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13206-11
21788497
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8501-6
23650345
Mol Microbiol. 2002 May;44(4):971-9
12010492
Nucleic Acids Res. 2011 Jul;39(13):5513-25
21422074
J Bacteriol. 2009 Feb;191(4):1191-9
19060138
Nat Chem Biol. 2013 Dec;9(12):811-7
24141193
Toxins (Basel). 2014 Jan 10;6(1):304-24
24434905
J Biol Chem. 2006 Dec 8;281(49):37942-51
16982615
MBio. 2015 Nov 17;6(6):e01765-15
26578681